Mesoblast
MESO
#4330
Rank
ยฃ1.81 B
Marketcap
ยฃ14.09
Share price
3.59%
Change (1 day)
65.70%
Change (1 year)

Mesoblast (MESO) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : ยฃ0.14 Billion

According to Mesoblast 's latest financial reports the company's total liabilities are ยฃ0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Mesoblast - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30ยฃ0.14 B13.23%
2023-06-30ยฃ0.13 B-2.9%
2022-06-30ยฃ0.13 B14.96%
2021-06-30ยฃ0.11 B-20.6%
2020-06-30ยฃ0.14 B10.38%
2019-06-30ยฃ0.13 B21.55%
2018-06-30ยฃ0.11 B3.8%
2017-06-30ยฃ0.10 B-8.66%
2016-06-30ยฃ0.11 B-41.54%
2015-06-30ยฃ0.20 B4.47%
2014-06-30ยฃ0.19 B14.86%
2013-06-30ยฃ0.16 B8.24%
2012-06-30ยฃ0.15 B-0.11%
2011-06-30ยฃ0.15 B14553.93%
2010-06-30ยฃ1.05 M46.29%
2009-06-30ยฃ0.71 M-8.99%
2008-06-30ยฃ0.79 M126.34%
2007-06-30ยฃ0.34 M-85.76%
2006-06-30ยฃ2.45 M96.86%
2005-06-30ยฃ1.24 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
ยฃ91.17 M-35.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
ยฃ2.36 M-98.32% Bahamas